Literature DB >> 7763417

Amino acid sequence of chymotrypsin inhibitor ECI from the seeds of Erythrina variegata (Linn.) var. Orientalis.

M Kimura1, Y Kouzuma, N Yamasaki.   

Abstract

The amino acids of the chymotrypsin inhibitor (ECI) from the Erythrina variegata seeds have been sequenced. The sequence was solved by analysis of peptides derived from the protein by enzymatic digestions with trypsin and Staphylococcus aureus V8 proteinase, as well as by chemical cleavage with o-iodosobenzoic acid. The ECI consists of 179 amino acid residues with a pyroglutamic acid as the N-terminal residue and has a calculated molecular weight of 19,791. Comparison of this sequence with the sequences of the two trypsin inhibitors, ETIa and ETIb, from the E. variegata seeds shows that about 60% of the residues of ECI are identical to those of ETIa and ETIb and that the reactive sites, Arg63, in ETIa and ETIb change to Leu64 in ECI.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7763417     DOI: 10.1271/bbb.57.102

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

1.  A wound-inducible gene from Salix viminalis coding for a trypsin inhibitor.

Authors:  P Saarikoski; D Clapham; S von Arnold
Journal:  Plant Mol Biol       Date:  1996-06       Impact factor: 4.076

2.  Trypsin inhibitor from Poecilanthe parviflora seeds: purification, characterization, and activity against pest proteases.

Authors:  Viviane Alves Garcia; Maria das Graças Machado Freire; José Camillo Novello; Sérgio Marangoni; Maria Lígia Rodrigues Macedo
Journal:  Protein J       Date:  2004-07       Impact factor: 2.371

3.  Characterization and pharmacological properties of a novel multifunctional Kunitz inhibitor from Erythrina velutina seeds.

Authors:  Richele J A Machado; Norberto K V Monteiro; Ludovico Migliolo; Osmar N Silva; Michele F S Pinto; Adeliana S Oliveira; Octávio L Franco; Sumika Kiyota; Marcelo P Bemquerer; Adriana F Uchoa; Ana H A Morais; Elizeu A Santos
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.